EXCLI Journal publishes original research reports, authoritative reviews and case reports of experimental and clinical sciences.
EXCLI Journal (eISSN 1611-2156) is particularly keen to keep a broad view of science and technology, and therefore welcomes papers which bridge disciplines and may not suit the narrow specialism of other journals. Although the general emphasis is on biological sciences, studies from the following fields are explicitly encouraged:
aging research, cell biology, clinical and preclinical research, drug development, environmental health, ergonomics, gastroenterology and hepatology, genetics, epigenetics and genomics, immunology, neuroscience and behavioral sciences, oncology and cancer research, pharmacology and toxicology, physiology, biochemistry and metabolomics, psychology, regenerative medicine and stem cell research, systems biology
Concerning EXCLI Journal's guidelines for sharing individual level patient data in submissions, please see this Editorial.
Read more about Guidelines for sharing individual level patient dataPublished continuously
Scientific Categories
(from 2022 onwards)
Cancer Research Human Factors Immunology Life Sciences Neuroscience Pharmacology/Toxicology
Scientific Forum
(from 2026 onwards)
Powered by
EXCLI Journal (eISSN 1611-2156) is a platinum open access journal. There are neither fees for authors submitting their papers nor fees for readers accessing PDFs of the published papers.
Articles published in EXCLI Journal are licensed under a Creative Commons Attribution 4.0 International License.
